In this issue:
Oral TYK2 inhibitor PF-06826647 for plaque psoriasis
Pregnancy outcomes in moderate-to-severe psoriasis
Secukinumab efficacy in nail psoriasis
Guselkumab for erythrodermic psoriasis
Treatment in paediatric patients with psoriasis followed into young adulthood
Risankizumab vs secukinumab for moderate-to-severe plaque psoriasis
Assessment of treatment satisfaction instruments in psoriasis
Swiss topical treatment of psoriasis vulgaris
Incidence of psoriasis among adults in the US
Please login below to download this issue (PDF)